Logo

Ciphergen Shares Slide 11 Percent After It Exchanged Debt, Cash

Nov 16, 2006
NEW YORK (GenomeWeb News) — Shares in Ciphergen were down 10.91 percent, or $.12, at $.98 in mid-afternoon trading today after the company said it finished exchanging $27.5 million worth of outstanding debt for a new series of notes worth $16.5 million, plus cash.

Ciphergen said it finished the exchange of 4.5-percent senior notes due 2008 for a new series of 7-percent convertible senior notes due 2011, together with $11 million in cash.

Breaking News
The Scan

Shape of Them All

According to BBC News, researchers have developed a protein structure database that includes much of the human proteome.

For Flu and More

The Wall Street Journal reports that several vaccine developers are working on mRNA-based vaccines for influenza.

To Boost Women

China's Ministry of Science and Technology aims to boost the number of female researchers through a new policy, reports the South China Morning Post.

Science Papers Describe Approach to Predict Chemotherapeutic Response, Role of Transcriptional Noise

In Science this week: neural network to predict chemotherapeutic response in cancer patients, and more.